Brickell Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Brickell Biotech's estimated annual revenue is currently $5M per year.
- Brickell Biotech's estimated revenue per employee is $201,000
Employee Data
- Brickell Biotech has 25 Employees.
- Brickell Biotech grew their employee count by 0% last year.
Brickell Biotech's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer/Co-Founder | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP, Global Regulatory Affairs | Reveal Email/Phone |
4 | VP, Head Clinical Operations | Reveal Email/Phone |
5 | General Counsel and Chief Compliance Officer | Reveal Email/Phone |
6 | Human Resources Manager | Reveal Email/Phone |
7 | Program and Alliance Management, Manager | Reveal Email/Phone |
Brickell Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | 0% | N/A | N/A |
#2 | $10.3M | 51 | 6% | N/A | N/A |
#3 | $4.4M | 22 | -8% | N/A | N/A |
#4 | $195M | 122 | 0% | $121.4M | N/A |
#5 | $4.8M | 24 | -20% | N/A | N/A |
#6 | $6.8M | 34 | -19% | N/A | N/A |
#7 | $4.8M | 24 | 0% | N/A | N/A |
#8 | $4M | 40 | -11% | $138M | N/A |
#9 | $4.8M | 24 | -14% | N/A | N/A |
#10 | $69.5M | 346 | -6% | N/A | N/A |
What Is Brickell Biotech?
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases. Brickell's pipeline consists of potential novel therapeutics for hyperhidrosis and other prevalent dermatological conditions. Brickell's executive management team and board of directors bring extensive experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and/or launched successful products, including several that were first-in-class and/or achieved iconic status, such as Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta® and Juvederm®. Brickell's strategy is to leverage this experience to in-license, acquire, develop and commercialize innovative products that Brickell believes can be successful in the currently underserved dermatology global marketplace.
keywords:N/A
N/A
Total Funding
25
Number of Employees
$5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Brickell Biotech News
Three analysts have made estimates for Brickell Biotech's earnings. The lowest EPS estimate is ($0.07) and the highest is ($0.05). Brickell...
Brickell Biotech Inc's score of 90 means that it ranks higher than 90% of stocks in the sector. In addition, its overall score of 46 ranks it...
Brickell Biotech Inc also received an overall rating of 63, putting it above 63% of all stocks. Biotechnology is ranked 68 out of the 148...
Other Companies in Boulder
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.7M | 25 | -7% | N/A |
#2 | $1.8M | 25 | 9% | N/A |
#3 | $3.2M | 25 | -11% | N/A |
#4 | $2.5M | 25 | 4% | N/A |
#5 | $2.9M | 25 | 4% | N/A |